AirSculpt Technologies, Inc. (AIRS) Free cash flow
- Free cash flow · 12 months (USD): Value $760.00K; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value 0.50%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $760.00K | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $1.28M − $517.00K ≈ $760.00K |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | 0.50% | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. $760.00K ÷ $150.72M × 100 ≈ 0.50% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $1.28M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | -0.11× | Operating cash flow / net income. Period ending 2026-06-30. $1.28M ÷ $-11.74M ≈ -0.11× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 1.28M USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | 517.00K USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | 760.00K USD | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 150.72M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | -11.74M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $760.00K | (m) | $1.28M | $517.00K | (m) | $150.72M | (m) | $-11.74M | (m) | (m) | 0.50% | -0.11× |
| 2026-03-31 | $6.95M | (m) | $7.50M | $554.00K | (m) | $151.84M | (m) | $-11.22M | (m) | (m) | 4.57% | -0.67× |
| 2025-12-31 | $692.00K | (m) | $3.10M | $2.40M | (m) | $151.82M | (m) | $-11.67M | (m) | (m) | 0.46% | -0.27× |
| 2025-09-30 | $2.47M | (m) | $8.34M | $5.87M | (m) | $157.55M | (m) | $-17.98M | (m) | (m) | 1.57% | -0.46× |
| 2025-06-30 | $-198.00K | (m) | $10.39M | $10.59M | (m) | $165.11M | (m) | $-14.51M | (m) | (m) | -0.12% | -0.72× |
| 2025-03-31 | $-5.49M | (m) | $8.85M | $14.35M | (m) | $172.10M | (m) | $-17.13M | (m) | (m) | -3.19% | -0.52× |
| 2024-12-31 | $-2.66M | (m) | $11.35M | $14.01M | (m) | $180.35M | (m) | $-8.25M | (m) | (m) | -1.47% | -1.38× |
| 2024-09-30 | $1.20M | (m) | $13.50M | $12.31M | (m) | $188.78M | (m) | $-7.79M | (m) | (m) | 0.63% | -1.73× |
| 2024-06-30 | $2.79M | (m) | $12.31M | $9.52M | (m) | $193.03M | (m) | $-3.42M | (m) | (m) | 1.44% | -3.60× |
| 2024-03-31 | $13.44M | (m) | $21.10M | $7.67M | (m) | $197.72M | (m) | $1.56M | (m) | (m) | 6.80% | 13.49× |
| 2023-12-31 | $14.04M | (m) | $23.96M | $9.92M | (m) | $195.92M | (m) | $-4.48M | (m) | (m) | 7.16% | -5.35× |
| 2023-09-30 | $15.44M | (m) | $25.73M | $10.29M | (m) | $189.01M | (m) | $-7.10M | (m) | (m) | 8.17% | -3.63× |
| 2023-06-30 | $12.67M | (m) | $25.42M | $12.76M | (m) | $181.11M | (m) | $-12.81M | (m) | (m) | 6.99% | -1.99× |
| 2023-03-31 | $11.12M | (m) | $23.59M | $12.46M | (m) | $175.06M | (m) | $-14.00M | (m) | (m) | 6.35% | -1.68× |
| 2022-12-31 | $11.53M | (m) | $24.45M | $12.92M | (m) | $168.79M | (m) | $-14.68M | (m) | (m) | 6.83% | -1.67× |
| 2022-09-30 | $-1.01M | (m) | $12.10M | $13.12M | (m) | $165.65M | (m) | $-21.64M | (m) | (m) | -0.61% | -0.56× |
| 2022-06-30 | $10.19M | (m) | $20.30M | $10.11M | (m) | $161.41M | (m) | $-6.21M | (m) | (m) | 6.31% | -3.27× |
| 2022-03-31 | $14.74M | (m) | $24.54M | $9.80M | (m) | $146.72M | (m) | $3.24M | (m) | (m) | 10.04% | 7.58× |
| 2021-12-31 | $19.52M | (m) | $26.63M | $7.12M | (m) | $133.31M | (m) | $10.55M | (m) | (m) | 14.64% | 2.52× |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $10.27M | (m) | $13.96M | $3.69M | (m) | $62.77M | (m) | $7.58M | (m) | (m) | 16.36% | 1.84× |
| 2019-12-31 | $499.00K | (m) | $4.94M | $4.44M | (m) | $41.24M | (m) | $-2.21M | (m) | (m) | 1.21% | -2.23× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |